Make a Gift
A gift to the Division of General Surgery helps us
discover
new treatments and cures.
Quan-Yang Duh, M.D.
Professor of Surgery
Chief, Section of Endocrine Surgery
Contact Information
VAMC, Surgical Services , SanFrancisco CA 94121
University ofCalifornia, SanFrancisco
San Francisco, CA94143
Voice:(415)750-2131
FAX: (415)514-1133
email: quan-yang.duh@med.va.gov
Education
-
1973-77, Yale University, New Haven, CT, B.S., Molecular Biophysics & Biochemistry
- 1977-81, University of California, San Francisco, M.D., Medicine
Residencies
- 1981-82, University of California, San Francisco, Intern, General Surgery
- 1982-88, University of California, San Francisco, Resident, General Surgery
Fellowships
-
1981-82, University of California, San Francisco, Postdoctoral Fellow, Surgery, General
-
1982-88, University of California, San Francisco, Postdoctoral Fellow, Surgery, General
Board Certification
- American Board of Surgery, 1989
Program Affiliations
- Endocrine Surgical Oncology Program
- UCSF Comprehensive Cancer Center
- Associate-Director, Videoscopic Training Program
Clinical Expertise
- Adrenal Tumors
- Adrenocortical Cancer
- Conn's Syndrome
- Cushing's Syndrome
- Goiter
- Hyperparathyroidism
- Laparoscopic Adrenalectomy
- Pheochromocytoma
- Thyroid Cancer
- Thyroid Nodule
Biography
Dr. Quan-Yang Duh is Professor of Surgery, Section Chief of Endocrine Surgery, Chief of Red General Surgery Service, Associate Director of Advanced Videoscopic Surgery Center, Attending Physician at the University of California, San Francisco. He is also Attending Surgeon at the San Francisco Veterans Affairs Medical Center.
Dr. Duh graduated from Yale University, New Haven, CT with a B.S. in Molecular Biophysics and Biochemistry. He completed his surgical internship, residency and postdoctoral fellowship at the University of California, in San Francisco He is board certified by the American Board of Surgery.
Dr. Duh is recognized internationally and nationally as an expert endocrine surgeon and advance laparoscopic surgeon. He specializes in the treatment of endocrine cancers and tumors, including those from the thyroid, parathyroid, pancreas and adrenal glands. He is an expert minimally invasive surgeon and performed laparoscopic adrenalectomy and laparoscopic hernia repair, and minimally invasive surgery for parathyroid and thyroid gland, as well as other complex laparoscopic and minimally invasive surgery.
Dr. Duh's research in endocrine cancer involved oncogenesis, genetic alteration and redifferentiation treatment of thyroid cancer and adrenal tumors. His clinical research involved patients with adrenal diseases (aldosteronoma, pheochromocytoma, Cushing, incidentaloma and adrenal metastasis), and minimally invasive parathyroid and thyroid operations. Dr. Duh has developed and actively teaches several new techniques for advance laparoscopic surgery. He has authored or co-authored more than 250 articles and textbook chapters on topics of endocrine surgery and laparoscopic surgery. Dr. Duh was the Site Principal Investigator for a multi-center Veterans Affairs Medical Center prospective randomized trail of open mesh versus laparoscopic inguinal hernia repair, the results of which was published in New England Journal of Medicine. He has started the program in robot-assisted laparoscopic general surgery at the VA Medical Center, currently focused on inguinal hernias.
Selected Publications
-
Shen WT, Sturgeon C, Clark OH, Duh QY, Kebebew E. Should pheochromocytoma size influence surgical approach? A comparison of 90 malignant and 60 benign pheochromocytomas. Surgery. 136: 1129-1137, 12/2004. Contribution: Conception of the study, critical analysis of the data, editing and revision of the paper, preparation of the presentation at AAES meeting where the paper was presented..
-
Sturgeon C, Shen WT, Clark OH, Duh QY, Kebebew E. Risk assessment in 457 adrenal cortical carcinomas : how much does tumor adrenal cortical carcinomas : how much does tumor size predict the likelihood of malignancy?. J Am Coll Surg Mar. 202: 423-30, 01/18/ 2006.Contribution: Conception of the study, critical analysis of the data, editing and revision of the paper..
-
Tan YY, Ogilvie JB, Triponez F, Caron NR, Kebebew EK, Clark OH, Duh QY. Selective Use of Adrenal Venous Sampling in the Lateralization of Aldosterone-producing Adenomas. World J Surg. 30: 879-885 , 04/ 17/2006. Contribution: Conception of the study, critical analysis of the data, editing and revision of the paper, preparation of the presentation at IAES meeting where the paper was presented, and defend the presentation as the senior author..
-
Shen WT, Lee J, Kebebew E, Clark OH, Duh QY. Selective use of steroid replacement after adrenalectomy: lessons from 331 consecutive cases. Arch Surg. 141: 771-6, 08/2006.Contribution: Conception of the study, critical analysis of the data, editing and revision of the paper, preparation of the presentation at Pacific Coast Surgical Assoicatioin meeting where the paper was presented and defending the presentation as the senior author..
-
Brunaud L, Kebebew E, Sebag F, Zarnegar R, Clark OH, Duh QY. Observation or laparoscopic adrenalectomy for adrenal incidentaloma? A surgical decision analysis. Med Sci Monit. 12: CR355-362 , 09/2006. Contribution: Conception of the study, critical analysis of the data and evaluation of the decision trees, editing and revision of the paper.
In the News
Endocrine Surgeons Leading Efforts to Identify Molecular Markers as Thyroid Cancers Rise
UCSF Today, CA - Feb 05, 2008Orlo H. Clark, M.D., former Chief of Surgery at UCSF Mount Zion, and his surgical colleagues Quan-Yang Duh, M.D., Wen T. Shen, M.D., and Jessica Gosnell, M.D. are leading efforts to identify molecular markers in biopsy tissue as the number of thyroid cases continue rise in the U.S.
